Ernest Doroszuk/Postmedia Network A clinical trial in France has left one brain dead. It's believed to have been testing out a new cannabis-based painkiller.
Damien Meye/AFP/Getty ImagesThis file photo taken on March 29, 2011 shows a view of the hospital center (CHU) of Pontchaillou in Rennes. A "serious accident" during a French trial of a cannabis-based painkiller has left one person brain-dead and five hospitalized in Rennes.
One of the people is on life support and is considered brain dead, the ministry said in an e-mailed statement on Friday. The treatment is being developed by a European drugmaker, according to statement, which didn’t name the compound or its developer.
The participants in the early-stage trial were healthy volunteers and the drug was taken orally, the ministry said. The six volunteers were taken to the University Hospital of Rennes, and others who took the treatment are being recalled.
The nation’s drug safety agency ANSM plans to inspect the clinical trial site. Marisol Touraine, the French minister for health, said she will also travel to the hospital and hold a press briefing between 3 and 4 p.m. Paris time. Her office was informed of the incident on Thursday night.
The drug being tested was a cannabis-based painkiller, according to French daily Le Figaro.
A spokeswoman for the Health Ministry declined to give further details including the laboratory’s name. The Paris prosecutor’s spokeswoman Agnes Thibaut-Lecuivre wasn’t immediately available for comment. Press officers at the ANSM and at the Rennes hospital declined to comment.